DLL3-BINDING IMMUNOCONJUGATES AND THEIR USES
AR135312A1Pending Publication Date: 2026-08-19ABDERA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100475
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-02-21
- Filing Date
- 2025-02-20
- Publication Date
- 2026-08-19
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
An immunoconjugate comprising an antibody bound to DLL3 linked (conjugated) to a compound, the compound comprising a structure represented by formula (II), formula (III), or formula (IV). A pharmaceutical composition comprising the immunoconjugate according to any one of claims 1-59 and a pharmaceutically acceptable excipient or carrier.